Held from 21-23 February 2023 in Boston, MA, the 2nd Next-Generation Conjugate Summit will feature expert speakers from companies including, Takeda Pharmaceutical, Elucida Oncology, Bicycle Therapeutics, Vincerx Pharma, Orum Therapeutics and Dyne Therapeutics.

The summit offers a unique platform committed to highlighting technologies and approaches to design conjugates with novel modes of action.

The event will be uniting more than one hundred thought leaders who are harnessing payloads including oligonucleotides, immune agonists, protein degraders and more, as well as novel formats including bispecifics, antibody fragments, targeted nanoparticles and bicycles.

This a great opportunity to be part of exclusive discussions on expanding the application of conjugate drugs and widening their therapeutic index to progress your next-generation conjugate from bench to bedside as fast as possible.

For more information please visit: https://next-gen-conjugates.com